يعرض 1 - 10 نتائج من 50 نتيجة بحث عن '"Bananis, E."', وقت الاستعلام: 1.00s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    العلاقة: pii: S0960-9776(22)00188-6; Rugo, H. S., Im, S. -A., Joy, A. A., Shparyk, Y., Walshe, J. M., Sleckman, B., Loi, S., Theall, K. P., Kim, S., Huang, X., Bananis, E., Mahtani, R., Finn, R. S. & Dieras, V. (2022). Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3. BREAST, 66, pp.324-331. https://doi.org/10.1016/j.breast.2022.11.005Test.; http://hdl.handle.net/11343/335416Test

  4. 4
    دورية أكاديمية

    العلاقة: pii: 707399; Cristofanilli, M., Rugo, H. S., Im, S. -A., Slamon, D. J., Harbeck, N., Bondarenko, I., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Iwata, H., O'Leary, B., Andre, F., Loibl, S., Bananis, E., Liu, Y., Huang, X., Kim, S., Frean, M. J. L. & Turner, N. C. (2022). Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study. CLINICAL CANCER RESEARCH, 28 (16), https://doi.org/10.1158/1078-0432.CCR-22-0305Test.; http://hdl.handle.net/11343/307658Test

  5. 5
    دورية أكاديمية

    العلاقة: Finn, R. S., Rugo, H. S., Gelmon, K. A., Cristofanilli, M., Colleoni, M., Loi, S., Schnell, P., Lu, D. R., Theall, K. P., Mori, A., Gauthier, E., Bananis, E., Turner, N. C. & Dieras, V. (2021). Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up. ONCOLOGIST, 26 (5), pp.E749-E755. https://doi.org/10.1002/onco.13684Test.; http://hdl.handle.net/11343/274179Test

  6. 6
    دورية أكاديمية
  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    مؤتمر